查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1541146

2024-2032 年按類型、產品、規模、應用和地區分類的醫藥精細化學品市場報告

Pharmaceutical Fine Chemicals Market Report by Type, Product, Size, Application, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 141 Pages | 商品交期: 2-3個工作天內

價格

IMARC Group年全球醫藥精細化學品市場規模達1,411億美元。

精細化學品是指生產數量有限、價格較高的一組純淨且複雜的化學品。它們是在多步驟批量生物技術方法的支持下在多功能工廠中生產的。與特種化學品不同，這些物質是根據其獨特的功能特徵和特定的分子特性精確累積的。收集後的精細化學品可用作生產硬脂酸鎂和明膠等多種醫藥化學產品的關鍵劑、穩定劑和溶劑。目前，它們以專有和非專有變體形式在商業上可用。

醫藥精細化學品市場趨勢：

各種神經系統和心血管疾病（包括心律不整、中風、癌症和冠狀動脈疾病）的盛行率不斷增加，特別是在老年族群中，是推動醫藥精細化學品市場成長的主要因素之一。據此，一些國家的政府機構採取了有利舉措，推出新型疫苗、藥物和藥物治療冠狀病毒疾病（COVID-19）和其他幾種疾病，這進一步促進了這些藥物在全球的廣泛採用。 。反過來，這也是市場成長的另一個推動因素。此外，在滿足品質標準的同時，執行不同的使用醫藥精細化學品作為原料生產藥品的指南也有助於市場成長。其他因素，例如製藥業的大幅擴張、研發 (R&D) 活動投資的增加以及消費者對多種疾病和可用藥物選擇的認知不斷增強，正在為全球市場創造積極的前景。

本報告回答的關鍵問題

  • 全球醫藥精細化學品市場有多大？ 2024-2032年全球醫藥精細化學品市場預計成長率為何？
  • 推動全球醫藥精細化學品市場的關鍵因素是什麼？
  • COVID-19對全球醫藥精細化學品市場有何影響？
  • 全球醫藥精細化學品市場按類型分類是怎樣的？
  • 以產品為基礎的全球醫藥精細化學品市場區隔是怎樣的？
  • 全球醫藥精細化學品市場按規模分類如何？
  • 全球醫藥精細化學品市場有哪些重點區域？
  • 全球醫藥精細化學品市場的主要參與者/公司有哪些？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球醫藥精細化學品市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按類型

  • 所有權
    • 市場趨勢
    • 市場預測
  • 非專有
    • 市場趨勢
    • 市場預測

第 7 章：市場區隔：依產品

  • 活性成分
    • 市場趨勢
    • 市場預測
  • 基本構建塊
    • 市場趨勢
    • 市場預測
  • 進階中級
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依規模

  • 大分子
    • 市場趨勢
    • 市場預測
  • 小分子
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按應用

  • 心血管
    • 市場趨勢
    • 市場預測
  • 神經病學
    • 市場趨勢
    • 市場預測
  • 腫瘤學
    • 市場趨勢
    • 市場預測
  • 呼吸系統
    • 市場趨勢
    • 市場預測
  • 胃腸道
    • 市場趨勢
    • 市場預測
  • 肌肉骨骼
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格分析

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • BASF SE
    • Borregaard ASA
    • CHEMADA Industries Ltd. (Turpaz)
    • Denisco Chemicals Pvt Ltd
    • Dupont De Nemours Inc.
    • Eastman Chemical Company
    • Evonik Industries AG
    • Koninklijke DSM NV
    • Lonza Group AG
    • Solvay SA
    • Syntor Fine Chemicals Ltd. (Aceto Corporation)
    • WR Grace and Co. (Standard Industries Inc.)
Product Code: SR112024A5910

The global pharmaceutical fine chemicals market size reached US$ 141.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 233.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.7% during 2024-2032.

Fine chemicals refer to a set of pure and complex chemicals that are manufactured in limited quantities at higher prices. They are produced in multipurpose plants with the support of a multistep batch biotechnological method. Unlike specialty chemicals, these substances are accumulated precisely based on their distinct functional characteristics and specific molecular properties. After collection, fine chemicals are used as key agents, stabilizers, and solvents for producing several pharmaceutical chemical products, including magnesium stearate and gelatin. At present, they are commercially available in proprietary and non-proprietary variants.

Pharmaceutical Fine Chemicals Market Trends:

The increasing prevalence of various neurological and cardiovascular diseases, including arrhythmias, stroke, cancer, and coronary artery ailments, especially amongst the geriatric population, is one of the prime factors driving the pharmaceutical fine chemical market toward growth. In line with this, favorable initiatives undertaken by the government bodies of several nations for introducing novel vaccines, drugs, and pharmaceutical medications for retaliating against coronavirus diseases (COVID-19) and several other disorders is further facilitating the widespread adoption of these medications in the healthcare sector. This, in turn, is acting as another growth-inducing factor in the market. Additionally, enforcement of different guidelines for utilizing pharmaceutical fine chemicals as raw materials to manufacture medicines, while meeting the quality standards is contributing to the market growth. Other factors, such as significant expansion in the pharmaceutical industry, increasing investments in the research and development (R&D) activities, and the growing consumer awareness regarding numerous disorders and the available medication options, are creating a positive outlook for the market across the globe.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmaceutical fine chemicals market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on type, product, size and application.

Breakup by Type:

Proprietary

Non-proprietary

Breakup by Product:

Active Ingredients

Basic Building Blocks

Advanced Intermediates

Breakup by Size:

Big Molecules

Small Molecules

Breakup by Application:

Cardiovascular

Neurological

Oncological

Respiratory

Gastrointestinal

Musculoskeletal

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being BASF SE, Borregaard ASA, CHEMADA Industries Ltd. (Turpaz), Denisco Chemicals Pvt Ltd, Dupont De Nemours Inc., Eastman Chemical Company, Evonik Industries AG, Koninklijke DSM N.V., Lonza Group AG, Solvay S.A., Syntor Fine Chemicals Ltd. (Aceto Corporation) and W. R. Grace and Co. (Standard Industries Inc.).

Key Questions Answered in This Report

  • 1. How big is the global pharmaceutical fine chemicals market?
  • 2. What is the expected growth rate of the global pharmaceutical fine chemicals market during 2024-2032?
  • 3. What are the key factors driving the global pharmaceutical fine chemicals market?
  • 4. What has been the impact of COVID-19 on the global pharmaceutical fine chemicals market?
  • 5. What is the breakup of the global pharmaceutical fine chemicals market based on the type?
  • 6. What is the breakup of the global pharmaceutical fine chemicals market based on the product?
  • 7. What is the breakup of the global pharmaceutical fine chemicals market based on the size?
  • 8. What are the key regions in the global pharmaceutical fine chemicals market?
  • 9. Who are the key players/companies in the global pharmaceutical fine chemicals market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Pharmaceutical Fine Chemicals Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Proprietary
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-proprietary
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Product

  • 7.1 Active Ingredients
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Basic Building Blocks
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Advanced Intermediates
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Size

  • 8.1 Big Molecules
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Small Molecules
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Cardiovascular
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Neurological
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Oncological
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Respiratory
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Gastrointestinal
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast
  • 9.6 Musculoskeletal
    • 9.6.1 Market Trends
    • 9.6.2 Market Forecast
  • 9.7 Others
    • 9.7.1 Market Trends
    • 9.7.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 BASF SE
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 Borregaard ASA
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
    • 15.3.3 CHEMADA Industries Ltd. (Turpaz)
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
    • 15.3.4 Denisco Chemicals Pvt Ltd
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 Dupont De Nemours Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Eastman Chemical Company
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Evonik Industries AG
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Koninklijke DSM N.V.
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 Lonza Group AG
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
      • 15.3.9.3 Financials
      • 15.3.9.4 SWOT Analysis
    • 15.3.10 Solvay S.A.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Syntor Fine Chemicals Ltd. (Aceto Corporation)
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
    • 15.3.12 W. R. Grace and Co. (Standard Industries Inc.)
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 SWOT Analysis

List of Figures

  • Figure 1: Global: Pharmaceutical Fine Chemicals Market: Major Drivers and Challenges
  • Figure 2: Global: Pharmaceutical Fine Chemicals Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 4: Global: Pharmaceutical Fine Chemicals Market: Breakup by Type (in %), 2023
  • Figure 5: Global: Pharmaceutical Fine Chemicals Market: Breakup by Product (in %), 2023
  • Figure 6: Global: Pharmaceutical Fine Chemicals Market: Breakup by Size (in %), 2023
  • Figure 7: Global: Pharmaceutical Fine Chemicals Market: Breakup by Application (in %), 2023
  • Figure 8: Global: Pharmaceutical Fine Chemicals Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Pharmaceutical Fine Chemicals (Proprietary) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Pharmaceutical Fine Chemicals (Proprietary) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Pharmaceutical Fine Chemicals (Non-proprietary) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Pharmaceutical Fine Chemicals (Active Ingredients) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Pharmaceutical Fine Chemicals (Basic Building Blocks) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Pharmaceutical Fine Chemicals (Advanced Intermediates) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Pharmaceutical Fine Chemicals (Big Molecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Pharmaceutical Fine Chemicals (Small Molecules) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Pharmaceutical Fine Chemicals (Cardiovascular) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Pharmaceutical Fine Chemicals (Neurological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Pharmaceutical Fine Chemicals (Neurological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Pharmaceutical Fine Chemicals (Oncological) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Pharmaceutical Fine Chemicals (Oncological) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Pharmaceutical Fine Chemicals (Respiratory) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Pharmaceutical Fine Chemicals (Respiratory) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Pharmaceutical Fine Chemicals (Gastrointestinal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Pharmaceutical Fine Chemicals (Musculoskeletal) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Pharmaceutical Fine Chemicals (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Pharmaceutical Fine Chemicals (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: North America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: North America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: United States: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: United States: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Canada: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Canada: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Asia-Pacific: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Asia-Pacific: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: China: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: China: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Japan: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Japan: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: India: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: India: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: South Korea: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: South Korea: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Australia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Australia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Indonesia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Indonesia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Europe: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Europe: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Germany: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Germany: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: France: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: France: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: United Kingdom: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: United Kingdom: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Italy: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Italy: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: Spain: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: Spain: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Russia: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Russia: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Latin America: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Latin America: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Brazil: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Brazil: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Mexico: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Mexico: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Others: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Others: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Middle East and Africa: Pharmaceutical Fine Chemicals Market: Breakup by Country (in %), 2023
  • Figure 85: Middle East and Africa: Pharmaceutical Fine Chemicals Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Pharmaceutical Fine Chemicals Industry: SWOT Analysis
  • Figure 87: Global: Pharmaceutical Fine Chemicals Industry: Value Chain Analysis
  • Figure 88: Global: Pharmaceutical Fine Chemicals Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Pharmaceutical Fine Chemicals Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Product (in Million US$), 2024-2032
  • Table 4: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Size (in Million US$), 2024-2032
  • Table 5: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Pharmaceutical Fine Chemicals Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Pharmaceutical Fine Chemicals Market: Competitive Structure
  • Table 8: Global: Pharmaceutical Fine Chemicals Market: Key Players